Castleark Management’s Idexx Laboratories IDXX Stock Holding History

Castleark Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-705	Closed	-$247K	–	306
2022 Q2	$247K	Hold	705	–	–	0.01%	255
2022 Q1	$386K	Hold	705	–	–	0.02%	257
2021 Q4	$464K	Hold	705	–	–	0.02%	267
2021 Q3	$438K	Hold	705	–	–	0.02%	258
2021 Q2	$445K	Hold	705	–	–	0.01%	258
2021 Q1	$345K	Sell	705 -1,135	-62%	-$569K	0.01%	275
2020 Q4	$920K	Hold	1,840	–	–	0.03%	248
2020 Q3	$723K	Buy	1,840 +510	+38%	+$189K	0.03%	247
2020 Q2	$439K	Hold	1,330	–	–	0.02%	267
2020 Q1	$322K	Buy	+1,330	New	+$347K	0.02%	258
2017 Q2	–	Sell	-17,480	Closed	-$2.7M	–	410
2017 Q1	$2.7M	Sell	17,480 -11,925	-41%	-$1.64M	0.08%	251
2016 Q4	$3.45M	Buy	29,405 +1,020	+4%	+$116K	0.11%	229
2016 Q3	$3.2M	Sell	28,385 -2,180	-7%	-$230K	0.1%	229
2016 Q2	$2.84M	Sell	30,565 -19,135	-39%	-$1.64M	0.09%	243
2016 Q1	$3.89M	Buy	+49,700	New	+$3.58M	0.12%	202

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Castleark Management's IDXX Position: Q3 2022 in Review

Castleark Management sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 705 shares — an estimated $247K sold.

Castleark Management first reported a position in IDXX in Q1 2016 and held it in 15 quarters. The position peaked at $3.89M in Q1 2016. 922 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Castleark Management reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
Castleark Management sold 705 Idexx Laboratories shares in Q3 2022, an estimated $247K.
Castleark Management first reported a position in Idexx Laboratories in Q1 2016 and held it in 15 quarters.
Castleark Management's Idexx Laboratories position peaked at $3.89M in Q1 2016.
922 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.